Unravelling the exposome of severe exacerbations of obstructive respiratory diseases in France
The study highlights how exposome factors influence bronchial diseases and underscores the benefit of open-access data for advancing research. COPD and asthma exacerbations account for numerous deaths and cost billions and will increase with global warming, identifying modifiable environmental risk factors, improving patient care and helping shape valuable public health policies.
Authors
- Aurélie Chekroun Martinot
- Mathieu Rosé
- Rosa Falotico
- Thomas Séjourné
- J. Cottet
- L. Antoniali
- Priscille de la Tour
- Tcherakian Colas
- Nicolas Molinari
- F. Fouad
- Isabella Annesi-Maesano
- Floriane Huret
- Christiane Pochulu
- Marcade Fulcrand Veronique
Institutions
- Institut national de recherche en sciences et technologies du numérique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Sanofi (France) (FR)
- La Ligue Contre le Cancer (FR)
- Les Hôpitaux de Chartres (FR)
- Société Française d'Allergologie (FR)
- Hôpital Foch (FR)
- Paris Biotech Santé (FR)
Publication Details
- Journal
- BMJ Open Respiratory Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1136/bmjresp-2025-003455
- Primary Topic
- Health, Environment, Cognitive Aging
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Sanofi
- Regeneron Pharmaceuticals